Morphological Transformations of SARS‐CoV‐2 Nucleocapsid Protein Biocondensates Mediated by Antimicrobial Peptides

Abstract

AbstractRecently, the discovery of antimicrobial peptides (AMPs) as excellent candidates for overcoming antibiotic resistance has attracted significant attention. AMPs are short peptides active against bacteria, cancer cells, and viruses. It has been shown that the SARS‐CoV‐2 nucleocapsid protein (N−P) undergoes liquid‐liquid phase separation in the presence of RNA, resulting in biocondensate formation. These biocondensates are crucial for viral replication as they concentrate the viral RNA with the host cell‘s protein machinery required for viral protein expression. Thus, N−P biocondensates are promising targets to block or slow down viral RNA transcription and consequently virion assembly. We investigated the ability of three AMPs to interfere with N−P/RNA condensates. Using microscopy techniques, supported by biophysical characterization, we found that the AMP LL–III partitions into the condensate, leading to clustering. Instead, the AMP CrACP1 partitions into the droplets without affecting their morphology but reducing their dynamics. Conversely, GKY20 leads to the formation of fibrillar structures after partitioning. It can be expected that such morphological transformation severely impairs the normal functionality of the N−P droplets and thus virion assembly. These results could pave the way for the development of a new class of AMP‐based antiviral agents targeting biocondensates.